Patient and public involvement
The study research question and outcome measures were developed in collaboration with the parent representatives of the adolescents with AIIRD, based on a shared priority to investigate the long-term immune response to the mRNA BNT162b2 vaccine. Parents and patients with AIIRD under the care of the medical centres conducting the trial were actively informed regarding the study and offered enrolment. The main study results will be disseminated to the parent representatives, who will help in the disseminating them through parent networks locally and abroad.